用小分子准NFE2L1信号,以保护其免受ferroptosis的侵害
Lucie Svobodová1, Jindřich Sedláček2, Zuzana Šmahelová2
1Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo n. 2, 16610 Prague, Czech Republic; Department of Organic Chemistry, Charles University, Hlavova 2030/8, Prague 2 12843, Czech Republic.
Bioorganic & medicinal chemistry letters
|October 5, 2025
概括
新化合物激活NFE2L1 (核因子红色素2相关因子1),这是细胞应激的关键调节者. 这些药物保护细胞免受铁亡,这是一种涉及神经退行和癌症的细胞死亡途径.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 药用化学 医学化学
背景情况:
- 铁亡是一种受调节的细胞死亡过程,与铁失调,氧化应激有关,并与神经退行和癌症等疾病有关.
- 核因子红色素2相关因子1 (NFE2L1) 是维持细胞平衡和减轻压力的关键转录因子.
- 调节铁亡是一种有希望的治疗途径,用于各种病理.
研究的目的:
- 设计和合成激活NFE2L1通路的新化合物.
- 在细胞模型中评估这些化合物对铁亡的细胞保护作用.
主要方法:
- 一系列 bis ((dimethoxybenzylidene) oxocyclohexylsulfonamides 和 sulfamides 的合成.
- 通过合成的化合物对NFE2L1激活的评估.
- 试验化合物在保护SH-SY5Y神经母细胞瘤细胞免受ferroptosis诱导剂 (erastin,RSL3,FAC) 的有效性.
主要成果:
- 成功设计和合成了新的硫胺和硫胺衍生物.
- 通过低微分子度的合成化合物证明了NFE2L1的强有力的激活.
- 观察到人类神经母细胞瘤细胞对多个ferroptosis诱导物的显著保护.
结论:
- 开发的化合物是强大的NFE2L1激活剂.
- 这些药物表现出对铁亡的显著细胞保护作用.
- 这些发现凸显了NFE2L1向剂对铁亡相关疾病的治疗潜力.
相关概念视频
Necrosis
6.3K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.3K
Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K

